Abstract

The aim of this study was to assess whether interleukin-10 (IL-10) and/or transforming growth factor beta-1 (TGFbeta1) downregulate HLA-DR expression using the HT29 cell line as a model of colonic epithelial cells. HLA-DR expression was induced in HT29 cells with gamma-interferon. The effects of IL-10 alone, TGFbeta1 alone, and IL-10 and TGFbeta1 in combination were studied. HLA-DR expression was assessed using flow cytometric analysis. Gamma-interferon induced HLA-DR expression in a dose-dependent fashion. In the absence of gamma-interferon, neither IL-10 nor TGFbeta1 induced HLA-DR expression. In isolation, neither IL-10 nor TGFbeta1 downregulated HLA-DR expression. When IL-10 and TGFbeta1 were added in combination, small (6-30%) statistically significant reductions in HLA-DR expression were seen. The biological significance is unclear.

Highlights

  • HLA-DR molecules are cell surface heterodimers that act as immune recognition molecules

  • HLA-DR molecules are not expressed by colonic epithelium,[4] colonic epithelial cell expression of HLA-DR is seen in a variety of inflammatory bowel diseases.[5,6]

  • On the basis of these results, neither transforming growth factor b (TGFb) 1 nor IL-10 acting in isolation downregulate g -interferon-induced expression of HLA-DR within this experimental system

Read more

Summary

Introduction

HLA-DR molecules are cell surface heterodimers that act as immune recognition molecules. A variety of antigen-presenting-cells present antigen in association with HLA-DR to lymphocytes. This interaction leads to lymphocyte activation and proliferation, and promotes inflammatory responses.[1] In addition to constitutive expression on a variety of cell types including lymphocytes, macrophages, vascular endothelium and some epithelial cells,[2] expression of HLADR molecules is induced in a much w ider range of cell types in the presence of inflammation.[3]. HLA-DR molecules are not expressed by colonic epithelium,[4] colonic epithelial cell expression of HLA-DR is seen in a variety of inflammatory bowel diseases.[5,6] In vitro studies have show n that HLA-DR-bearing colonic epithelial cells can present antigen to mucosal lymphocytes.[7,8] It is likely that HLA-DR expression by colonic epithelial cells is an important step in the generation of mucosal immune responses

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call